|
HY-130419-25ug
|
MedChemexpress LLC
|
(±)13(14)-EpDPA [CAS 895127-64-7] (290.28 μM * 250 μL in Ethanol)
|
|
|
|
|
HY-134903-100mg
|
MedChemexpress LLC
|
(32-Carbonyl)-RMC-5552 [CAS 2382768-55-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-134903-10mg
|
MedChemexpress LLC
|
(32-Carbonyl)-RMC-5552 [CAS 2382768-55-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-134903-25mg
|
MedChemexpress LLC
|
(32-Carbonyl)-RMC-5552 [CAS 2382768-55-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-134903-50mg
|
MedChemexpress LLC
|
(32-Carbonyl)-RMC-5552 [CAS 2382768-55-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-134903-5mg
|
MedChemexpress LLC
|
(32-Carbonyl)-RMC-5552 [CAS 2382768-55-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-N0346A-10mg
|
MedChemexpress LLC
|
(E)-Ethyl p-methoxycinnamate [CAS 24393-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0346A-25mg
|
MedChemexpress LLC
|
(E)-Ethyl p-methoxycinnamate [CAS 24393-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0346A-5mg
|
MedChemexpress LLC
|
(E)-Ethyl p-methoxycinnamate [CAS 24393-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0346A-1mL
|
MedChemexpress LLC
|
(E)-Ethyl p-methoxycinnamate [CAS24393-56-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N3102A-10mg
|
MedChemexpress LLC
|
(E)-p-Coumaryl alcohol [CAS 20649-40-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3102A-25mg
|
MedChemexpress LLC
|
(E)-p-Coumaryl alcohol [CAS 20649-40-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3102A-50mg
|
MedChemexpress LLC
|
(E)-p-Coumaryl alcohol [CAS 20649-40-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3102A-5mg
|
MedChemexpress LLC
|
(E)-p-Coumaryl alcohol [CAS 20649-40-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N1356A-1mg
|
MedChemexpress LLC
|
(R)-Reticuline [CAS 3968-19-2]
|
|
|
|
|
HY-N1356A-5mg
|
MedChemexpress LLC
|
(R)-Reticuline [CAS 3968-19-2]
|
|
|
|
|
HY-N1356A-10mg
|
MedChemexpress LLC
|
(R)-Reticuline [CAS3968-19-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-13212-10mg
|
MedChemexpress LLC
|
(Z)-2-Decenoic acid [CAS 15790-91-7]
|
|
Cancer-programmed cell death
|
|
|
HY-13212-5mg
|
MedChemexpress LLC
|
(Z)-2-Decenoic acid [CAS 15790-91-7]
|
|
Cancer-programmed cell death
|
|
|
HY-13212-1mL
|
MedChemexpress LLC
|
(Z)-2-Decenoic acid [CAS 15790-91-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P1159A-10mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1159A-1mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1159A-5mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P3801-10mg
|
MedChemexpress LLC
|
[Glp5,(Me)Phe8,Sar9] Substance P (5-11) [CAS77128-69-9]
|
|
|
|
|
HY-P3801-1mg
|
MedChemexpress LLC
|
[Glp5,(Me)Phe8,Sar9] Substance P (5-11) [CAS77128-69-9]
|
|
|
|
